Taking the cell by stealth or storm? Protein Transduction Domains (PTDs) as versatile vectors for delivery

被引:31
作者
Bogoyevitch, MA
Kendrick, TS
Ng, DCH
Barr, RK
机构
[1] Univ Western Australia, Cell Signalling Lab, Sch Biomed & Chem Sci, Crawley, WA 6009, Australia
[2] Western Australian Inst Med Res, Perth, WA 6000, Australia
关键词
D O I
10.1089/104454902762053846
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A cell delivery system is increasing in use in many areas of cell and molecular biology and bio-medicine. This system is based on a number of naturally occurring protein motifs and/or sequences which show the remarkable ability to rapidly cross the mammalian cell membrane without compromising its structure or function. These so-called Protein Transduction Domains (PTDs) offer unprecedented advantages for intracellular delivery. These advantages include, but are not limited to, their applicability to all cell types (no cell type has yet been described which is not transduced by these PTDs), and the range of cargoes that can be transduced (including peptides, small proteins, full-length enzymes, DNA oligomers, peptide-nucleic acid oligomers, liposomes, and magnetic nanoparticles). Furthermore, the PTDs have been demonstrated to be suitable for in vivo delivery including delivery across the blood brain barrier, and have been shown to cross the plasma membrane rapidly and enter the cytoplasm and nuclear regions of the cell. In this review, the general properties of the most commonly used PTDs are described. The strategies currently being undertaken also highlight that improvements in membrane transduction are possible despite our lack of understanding of the exact biochemical and/or physical mechanisms of transduction. Recent examples of the range of potential applications are also discussed.
引用
收藏
页码:879 / 894
页数:16
相关论文
共 93 条
  • [51] A peptide carrier for the delivery of biologically active proteins into mammalian cells
    Morris, MC
    Depollier, J
    Mery, J
    Heitz, F
    Divita, G
    [J]. NATURE BIOTECHNOLOGY, 2001, 19 (12) : 1173 - 1176
  • [52] A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
    Morris, MC
    Vidal, P
    Chaloin, L
    Heitz, F
    Divita, G
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (14) : 2730 - 2736
  • [53] Targeting large molecules to mitochondria
    Muratovska, A
    Lightowlers, RN
    Taylor, RW
    Wilce, JA
    Murphy, MP
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 49 (1-2) : 189 - 198
  • [54] Peptide nucleic acids as therapeutic agents
    Nielsen, PE
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 1999, 9 (03) : 353 - 357
  • [55] Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically
    Oehlke, J
    Scheller, A
    Wiesner, B
    Krause, E
    Beyermann, M
    Klauschenz, E
    Melzig, M
    Bienert, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1414 (1-2): : 127 - 139
  • [56] Extensive cellular-uptake into endothelial cells of an amphipathic beta-sheet forming peptide
    Oehlke, J
    Krause, E
    Wiesner, B
    Beyermann, M
    Bienert, M
    [J]. FEBS LETTERS, 1997, 415 (02) : 196 - 199
  • [57] alpha v Integrins as receptors for tumor targeting by circulating ligands
    Pasqualini, R
    Koivunen, E
    Ruoslahti, E
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (06) : 542 - 546
  • [58] Peck D, 1998, J CELL SCI, V111, P1595
  • [59] Penetratin-induced aggregation and subsequent dissociation of negatively charge phospholipid vesicles
    Persson, D
    Thorén, PEG
    Nordén, B
    [J]. FEBS LETTERS, 2001, 505 (02): : 307 - 312
  • [60] Pescarolo MP, 2001, FASEB J, V15, P31